Another vote for python+cctbx.
And a bit of fun: http://xkcd.com/224/ http://xkcd.com/297/ http://xkcd.com/353/ http://comicjk.com/comic.php/217 http://comicjk.com/comic.php/823 http://comicjk.com/comic.php/842 http://comicjk.com/comic.php/849 From: CCP4 bulletin board [mailto:CCP4BB@JISCMAIL.AC.UK] On Behalf Of Frank von Delft Sent: 24 January 2012 15:08 To: CCP4BB@JISCMAIL.AC.UK Subject: Re: [ccp4bb] writing scripts-off topic What an astonishingly low bar.... On 24/01/2012 14:19, David Schuller wrote: On 01/24/12 00:41, Bart Hazes wrote: I have used a number of languages and have found only one I really disliked, that being perl. It is hard for me to imagine that this language was developed by a linguist yet in my eyes it is the least natural language from human comprehension point of view. In contrast, python is much more intuitive and should be very suitable for the tasks you describe. www.cs.siue.edu/~astefik/papers/StefikPlateau2011.pdf <http://www.cs.siue.edu/%7Eastefik/papers/StefikPlateau2011.pdf> An Empirical Comparison of the Accuracy Rates of Novices using the Quorum, Perl, and Randomo Programming Languages A. Stefik, S. Siebert, M. Stefik, K. Slattery Abstract: "... Perl users were unable to write programs more accurately than those using a language designed by chance." -- ======================================================================= All Things Serve the Beam ======================================================================= David J. Schuller modern man in a post-modern world MacCHESS, Cornell University schul...@cornell.edu -------------------------------------------------------------------------- AstraZeneca UK Limited is a company incorporated in England and Wales with registered number: 03674842 and a registered office at 2 Kingdom Street, London, W2 6BD. Confidentiality Notice: This message is private and may contain confidential, proprietary and legally privileged information. If you have received this message in error, please notify us and remove it from your system and note that you must not copy, distribute or take any action in reliance on it. Any unauthorised use or disclosure of the contents of this message is not permitted and may be unlawful. Disclaimer: Email messages may be subject to delays, interception, non-delivery and unauthorised alterations. Therefore, information expressed in this message is not given or endorsed by AstraZeneca UK Limited unless otherwise notified by an authorised representative independent of this message. No contractual relationship is created by this message by any person unless specifically indicated by agreement in writing other than email. Monitoring: AstraZeneca UK Limited may monitor email traffic data and content for the purposes of the prevention and detection of crime, ensuring the security of our computer systems and checking Compliance with our Code of Conduct and Policies.
